JP2018108974A - Hair restorer - Google Patents
Hair restorer Download PDFInfo
- Publication number
- JP2018108974A JP2018108974A JP2017000752A JP2017000752A JP2018108974A JP 2018108974 A JP2018108974 A JP 2018108974A JP 2017000752 A JP2017000752 A JP 2017000752A JP 2017000752 A JP2017000752 A JP 2017000752A JP 2018108974 A JP2018108974 A JP 2018108974A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- fulvic acid
- acid
- humus
- humus extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 72
- 239000002509 fulvic acid Substances 0.000 claims abstract description 58
- 239000003864 humus Substances 0.000 claims abstract description 57
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 claims abstract description 55
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 claims abstract description 55
- 229940095100 fulvic acid Drugs 0.000 claims abstract description 55
- 239000000284 extract Substances 0.000 claims abstract description 50
- 238000010521 absorption reaction Methods 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000000862 absorption spectrum Methods 0.000 claims abstract description 12
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 claims abstract description 9
- 239000000654 additive Substances 0.000 claims abstract description 4
- 235000013373 food additive Nutrition 0.000 claims abstract description 4
- 239000002778 food additive Substances 0.000 claims abstract description 4
- 230000000996 additive effect Effects 0.000 claims abstract 2
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 239000000839 emulsion Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000007910 chewable tablet Substances 0.000 claims description 3
- 239000004927 clay Substances 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 229940068682 chewable tablet Drugs 0.000 claims 1
- 229940023488 pill Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 210000004027 cell Anatomy 0.000 description 28
- 230000000052 comparative effect Effects 0.000 description 25
- 230000003779 hair growth Effects 0.000 description 23
- 238000012360 testing method Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 11
- -1 tri-substituted benzene Chemical class 0.000 description 11
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 10
- 230000010261 cell growth Effects 0.000 description 10
- 239000004021 humic acid Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000002500 effect on skin Effects 0.000 description 9
- 239000002689 soil Substances 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 230000004663 cell proliferation Effects 0.000 description 8
- 229960004039 finasteride Drugs 0.000 description 8
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000002189 fluorescence spectrum Methods 0.000 description 5
- 239000005416 organic matter Substances 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 238000000134 MTT assay Methods 0.000 description 3
- 231100000002 MTT assay Toxicity 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 239000003966 growth inhibitor Substances 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000011071 total organic carbon measurement Methods 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RNNHLXAEVKCLDG-UHFFFAOYSA-N 2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,9,2,4,6,8,10-pentaoxapentasilecane Chemical compound C[Si]1(C)O[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 RNNHLXAEVKCLDG-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- WADQOGCINABPRT-UHFFFAOYSA-N 3-chloro-2-methylphenol Chemical compound CC1=C(O)C=CC=C1Cl WADQOGCINABPRT-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 102100037815 Fas apoptotic inhibitory molecule 3 Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 101000878510 Homo sapiens Fas apoptotic inhibitory molecule 3 Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- RCYWWJBNPIWJMJ-UHFFFAOYSA-N [4-(hexadecanoyloxymethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCCCCCCCCCC RCYWWJBNPIWJMJ-UHFFFAOYSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229920006125 amorphous polymer Polymers 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 102000001307 androgen receptors Human genes 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 238000005102 attenuated total reflection Methods 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000012844 infrared spectroscopy analysis Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001819 propan-2-yl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- RGACABDFLVLVCT-UHFFFAOYSA-N propan-2-yl 3-phenylprop-2-enoate Chemical compound CC(C)OC(=O)C=CC1=CC=CC=C1 RGACABDFLVLVCT-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940095042 pyridoxine dipalmitate Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- AEEZIRBYGITPDN-UHFFFAOYSA-M sodium;dodecanoyl sulfate Chemical compound [Na+].CCCCCCCCCCCC(=O)OS([O-])(=O)=O AEEZIRBYGITPDN-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、育毛剤に関し、より詳細には腐植抽出物を含有する育毛剤に関する。 The present invention relates to a hair restorer, and more particularly to a hair restorer containing a humus extract.
毛髪の成長は、毛母細胞の増殖と分化によって起こり、そして毛乳頭細胞によって調節されていることが知られている(非特許文献1)。毛乳頭細胞の集合体である毛乳頭は、毛髪の成長期に大きく成長することから、毛乳頭細胞の増殖が、太くてしっかりした毛髪を形成する重要な役割を果たしていると考えられる。 It is known that hair growth occurs by proliferation and differentiation of hair matrix cells and is regulated by hair papilla cells (Non-patent Document 1). The dermal papilla, which is an aggregate of dermal papilla cells, grows greatly during the growth phase of the hair. Therefore, it is considered that the proliferation of dermal papilla cells plays an important role in forming thick and firm hair.
毛乳頭細胞の増加は、EGFやFGFといった細胞増殖因子によって促進される、男性ホルモンの一種であり、動物試験等で細胞増殖抑制物質として知られているジヒドロテストステロン(DHT)の産生抑制等が考えられる。したがって、育毛促進方法として、従来、EGF、FGF等の細胞増殖因子を活性化させる方法、DHT等の細胞増殖抑制物質を抑制させる方法等が検討されている。後述の実施例で陽性対照として使用した、抗アンドロゲン薬として知られるフィナステリド(Finasteride)は、EGFやFGFの産生促進というよりも、5αリダクターゼ阻害剤として作用が強いため、阻害作用の結果として、毛乳頭細胞に含まれるアンドロゲンレセプターへ関与し、細胞増殖を示したと考えられている。ミノキシジルもまた、フィナステリドと同様の作用機序と思われる。 The increase in dermal papilla cells is a type of male hormone that is promoted by cell growth factors such as EGF and FGF, and is considered to suppress the production of dihydrotestosterone (DHT), which is known as a cell growth inhibitor in animal studies. It is done. Therefore, conventionally, methods for activating cell growth factors such as EGF and FGF, methods for suppressing cell growth inhibitors such as DHT, and the like have been studied as methods for promoting hair growth. Finasteride, which is known as an antiandrogen used as a positive control in Examples described later, is more effective as a 5α-reductase inhibitor than EGF or FGF production promotion. It is thought to be involved in the androgen receptor contained in the papillary cells and showed cell proliferation. Minoxidil also appears to have a similar mechanism of action as finasteride.
特許文献1には、腐植土抽出物を含むことを特徴とする育毛剤が開示されている。特許文献1でによれば、人体に優しく、かつ、使用感、保湿効果に優れた育毛剤を提供可能であるとされる。特許文献2には、腐植土抽出物質含有水性液を用いて増毛剤・育毛剤を製造することが開示されている。特許文献1及び特許文献2の実施例で使用された腐植土抽出液は、長崎県北高来郡森山町唐比西名で採取された腐植土の抽出物である。この腐植土抽出物が、後述の比較例2で使用した市販の育毛剤に含まれている。 Patent Document 1 discloses a hair growth agent characterized by containing a humus soil extract. According to Patent Document 1, it is said that it is possible to provide a hair restorer that is gentle to the human body and that has an excellent feeling of use and a moisturizing effect. Patent Document 2 discloses that a hair thickener and a hair restorer are produced using an aqueous liquid containing a humus extract material. The humus soil extract used in the examples of Patent Document 1 and Patent Document 2 is an extract of humus soil collected from Kara Nishina, Moriyama-machi, Kitakaku-gun, Nagasaki Prefecture. This humus soil extract is contained in the commercially available hair restorer used in Comparative Example 2 described later.
腐植は、一般に、約1億年前の多くの栄養素が含まれた肥沃な土壌が石油や石炭に変性することなく、有機物として残存したものである。より詳細には、前記時代に生息した植物が、氷河期に入ると地下に埋没し、バクテリア等の微生物によってピートモスに変化し、その上に新しい有機物が積み重なって、再度、バクテリア等で分解され、時間の経過とともに堆積層を形成したものである。腐植は、土壌中で植物残渣や微生物遺体の中の炭水化物及びタンパク質が微生物によって分解され、さらにその分解産物が縮合してできたフルボ酸やフミン酸といった無定形有機高分子重合体や、多種類のミネラルを含有する。フミン酸は、アルカリに可溶であって酸に不溶な赤褐色ないし黒褐色無定形高分子有機酸であり、フルボ酸は、アルカリ及び酸に可溶な無定形高分子有機酸である。 In general, humus is a fertilized soil containing many nutrients approximately 100 million years old that remains as organic matter without being transformed into oil or coal. More specifically, when the plant that inhabited the period entered the ice age, it was buried underground, changed to peat moss by microorganisms such as bacteria, and new organic matter accumulated on top of it, and again decomposed by bacteria etc. A deposited layer is formed as the process proceeds. Humus is an amorphous organic polymer such as fulvic acid or humic acid, which is formed by the decomposition of carbohydrates and proteins in plant residues and microbial remains in the soil by microorganisms, and the decomposition products are condensed. Contains minerals. Humic acid is a red-brown or black-brown amorphous high-molecular organic acid that is soluble in alkali and insoluble in acid, and fulvic acid is an amorphous high-molecular organic acid that is soluble in alkali and acid.
フルボ酸やフミン酸のような無定形重合高分子有機酸は、腐植の産地の土壌やその生成年代期等の要因によって変化する。腐植の効能もまた、無定形重合高分子有機酸の構造や物性の相違によって変化すると考えられる。 Amorphous polymeric organic acids such as fulvic acid and humic acid vary depending on factors such as the soil of the humus production area and the age of its generation. The effect of humus is also considered to change due to the difference in the structure and physical properties of the amorphous polymer organic acid.
そこで、本発明の課題は、腐植抽出物質を含有し、育毛作用に優れた育毛剤を提供することである。 Then, the subject of this invention is providing the hair restoring agent which contains humus extract substance and was excellent in the hair growth effect | action.
本発明者は、上記課題を鋭意検討した結果、多種多様な分子構造と置換基を有するフルボ酸の中でも特定の赤外線吸収に基づく構造を有するフルボ酸には、従来、フィナステリドのように育毛作用を発揮し、さらに、従来公知の腐植抽出物含有育毛剤と対比しても優れた育毛作用に発揮することを発見し、本発明を完成させた。すなわち、本発明は、FT−IR法における赤外線吸収スペクトルにおいて波数3362,2875,1675,1559,1360,1200,1047及び835cm−1に赤外線吸収ピークを有するフルボ酸を含有する腐植抽出物を有効量含み、そして化粧品学的、皮膚病学的及び/又は薬学的に許容される添加剤あるいは食品添加物を含んでなる育毛剤を提供する。本明細書において、「育毛剤」は、育毛効果のほかに発毛効果を含む意味で使用される。 As a result of intensive studies on the above problems, the inventor of the present invention has hitherto been known to have a hair growth action like finasteride on a fulvic acid having a structure based on specific infrared absorption among fulvic acids having various molecular structures and substituents. Furthermore, the present invention was completed by discovering that it exhibited an excellent hair growth action even when compared with a conventionally known humus extract-containing hair restorer. That is, the present invention provides an effective amount of a humus extract containing fulvic acid having infrared absorption peaks at wave numbers 3362, 2875, 1675, 1559, 1360, 1200, 1047 and 835 cm −1 in the infrared absorption spectrum in the FT-IR method. And a hair restorer comprising cosmetic, dermatological and / or pharmaceutically acceptable additives or food additives. In the present specification, the “hair growth agent” is used in the meaning including a hair growth effect in addition to the hair growth effect.
前記腐植抽出物は、より特定的には、図1に示す赤外線吸収スペクトルを示すフルボ酸を含有する。 More specifically, the humus extract contains fulvic acid having an infrared absorption spectrum shown in FIG.
前記腐植抽出物は、ナフタレン環構造を有さないことが好ましい。 It is preferable that the said humus extract does not have a naphthalene ring structure.
前記腐植抽出物中のフルボ酸の平均分子量は、4,000よりも小さいことが好ましい。 The average molecular weight of the fulvic acid in the humus extract is preferably less than 4,000.
本発明の育毛剤は、例えば経皮投与用である。 The hair restorer of the present invention is for example for transdermal administration.
前記経皮投与用の育毛剤の形態は、例えば水剤、液剤、乳剤、乳液、エマルション、クリーム、粉体、又はクレイパックである。 The form of the hair growth agent for transdermal administration is, for example, a liquid agent, a liquid agent, an emulsion, an emulsion, an emulsion, a cream, a powder, or a clay pack.
本発明の育毛剤は、例えば経口投与用である。 The hair restorer of the present invention is for oral administration, for example.
前記経口投与用の育毛剤の形態は、例えば散剤、顆粒剤、カプセル剤、丸剤、錠剤、チュアブル錠、ドロップ、水剤、シロップ、又はドリンク剤である。 Examples of the hair-restoring agent for oral administration are powders, granules, capsules, pills, tablets, chewable tablets, drops, liquids, syrups, or drinks.
特定の赤外線吸収波長によって規定されるフルボ酸を含有する腐植抽出物を含有することを特徴とする本発明の育毛剤によれば、フィナステリドのように育毛作用が発揮され、しかも、その効能は腐植抽出物を含有する公知の腐植物質含有育毛剤よりも顕著に高い。 According to the hair restorer of the present invention, which contains a humus extract containing a fulvic acid defined by a specific infrared absorption wavelength, the hair restoring action is exerted like finasteride, and its effect is humus It is significantly higher than known humic substance-containing hair restorers containing extracts.
以下、本発明の実施の形態を詳細に説明する。本発明の育毛剤は、FT−IR法における赤外線吸収スペクトルにおいて波数3362,2875,1675,1559,1360,1200,1047及び835cm−1に赤外線吸収ピークを有するフルボ酸を含有する腐植抽出物を有効量含む。 Hereinafter, embodiments of the present invention will be described in detail. The hair restorer of the present invention effectively uses a humus extract containing fulvic acid having infrared absorption peaks at wave numbers 3362, 2875, 1675, 1559, 1360, 1200, 1047 and 835 cm −1 in the infrared absorption spectrum in the FT-IR method. Including quantity.
本発明の育毛剤には、腐植抽出物の中でも、上記した特定の赤外線吸収ピークを有する腐植抽出物を使用することを必須とする。腐植抽出物は、上記の赤外線吸収特性を有するものであれば、その由来を問わない。 In the hair restorer of this invention, it is essential to use the humus extract which has the above-mentioned specific infrared absorption peak among humus extracts. A humus extract will not ask | require the origin, if it has said infrared absorption characteristic.
上記赤外線吸収ピークを有する腐植抽出物を含んだ腐植を水(例えば蒸留水、イオン交換水、逆浸透圧水等)と混合することにより、腐植抽出物が水内に抽出される。その際、腐植を、水100重量部に対して通常、5〜35重量部、好ましくは15〜25重量部、特に好ましくは、17〜18重量部の割合で混合する。上記混合物を、室温で、通常、24〜96時間、好ましくは48〜72時間日間放置する。上記放置中、適宜、混合物を撹拌してもよい。次いで、上記混合物の上澄液又は濾液を腐植抽出物とする。液状の腐植抽出物のpHは、通常、3.0である。この液状の腐植抽出物を乾固して、粉末としてもよい。 By mixing the humus containing the humus extract having the infrared absorption peak with water (for example, distilled water, ion exchange water, reverse osmotic pressure water, etc.), the humus extract is extracted into the water. In that case, humus is normally mixed in 5-35 weight part with respect to 100 weight part of water, Preferably it is 15-25 weight part, Most preferably, it is a ratio of 17-18 weight part. The mixture is left at room temperature, usually for 24 to 96 hours, preferably 48 to 72 hours. During the standing, the mixture may be appropriately stirred. Next, the supernatant or filtrate of the above mixture is used as a humus extract. The pH of the liquid humus extract is usually 3.0. This liquid humus extract may be dried to a powder.
上記腐植抽出物中のフルボ酸の平均分子量は、通常、4,000よりも小さく、好ましくは3,500以下であり、特に好ましくは3,000以下であり、さらに好ましくは3,000〜1,000である。 The average molecular weight of the fulvic acid in the humus extract is usually less than 4,000, preferably 3,500 or less, particularly preferably 3,000 or less, more preferably 3,000 to 1, 000.
前記腐植抽出物は、市販のものでもよく、日本では例えば株式会社スタイルアンドバリュージャパンより製品名「ヒューミクル(登録商標)HCフルボ酸パウダー」として入手可能である。ヒューミクルの成分分析結果(試料湿重量中の含有量)を、表1に示す。 The humus extract may be commercially available, and is available in Japan under the product name “Humicle (registered trademark) HC fulvic acid powder” from, for example, Style and Value Japan. Table 1 shows the component analysis results (content in the sample wet weight).
ヒューミクルの4%水溶液の全有機炭素(TOC)の測定、及びフルボ酸分画の全有機炭素(TOC)測定の結果から、ヒューミクル中の炭素のほぼ全量が有機炭素で占められ、そして有機炭素のほぼ全量がフルボ酸を構成していることが確認された。そして、ヒューミクル中のフルボ酸含有量は、約3%と推定された。 From the results of the total organic carbon (TOC) measurement of the 4% aqueous solution of Humicle and the total organic carbon (TOC) measurement of the fulvic acid fraction, almost all of the carbon in the Humicle is occupied by organic carbon, and the organic carbon It was confirmed that almost the entire amount constituted fulvic acid. The fulvic acid content in the fumicle was estimated to be about 3%.
ヒューミクルのアルカリ(0.1N水酸化ナトリウム)及び酸(塩酸、pH2)可溶成分を抽出することにより、フルボ酸を分画した。ヒューミクル又はフルボ酸分画の物性試験方法とその分析結果を以下に示す。 Fulvic acid was fractionated by extracting the fumaric alkali (0.1N sodium hydroxide) and acid (hydrochloric acid, pH 2) soluble components. The physical property test method and analysis results of the fumicle or fulvic acid fraction are shown below.
(1)3次元分光蛍光光度法
ヒューミクルの4%水溶液の3次元励起−蛍光スペクトル(測定装置JASCO FP−8200)を図3に示す。比較のため、愛知県段戸森林土壌から抽出精製されたフルボ酸及びフミン酸(いずれも、日本腐植物質学会から「日本腐植物質学会 標準資料」として頒布されている、以下、それぞれ、段戸産フルボ酸及び段戸産フミン酸という)の3次元蛍光スペクトルを図4に示す。ヒューミクル及び段戸産フルボ酸の3次元励起−蛍光スペクトルには、フルボ酸由来の蛍光の特徴である、励起250nm付近−蛍光430nm付近のピーク及び、励起320nm付近−蛍光430nm付近のピークが出現している。
(1) Three-dimensional spectrofluorimetry The three-dimensional excitation-fluorescence spectrum (measuring device JASCO FP-8200) of a 4% aqueous solution of Humicle is shown in FIG. For comparison, fulvic acid and humic acid extracted and refined from Danto forest soil in Aichi Prefecture (both are distributed as “Standard Material of the Japanese Humic Society” by the Japanese Humic Society, respectively) FIG. 4 shows three-dimensional fluorescence spectra of fulvic acid and corrugated humic acid. In the three-dimensional excitation-fluorescence spectrum of Humicle and Danto's fulvic acid, there are peaks of excitation around 250 nm-fluorescence near 430 nm and excitation around 320 nm-fluorescence near 430 nm, which are characteristic of fluorescence derived from fulvic acid. ing.
(2)GPC−UV/TC分析
GPC−UV/TC分析法は、水中溶存有機物を分子の大きさや排除の程度によって高速に分離し、分離した溶存分子をUV検出器及びTC検出器(Total Carbon Analyzer)でモニタリングする手法である。以下GPC−TC装置:
GPC:Shodex GPC SYSTEM 21
分離カラム TOSO HW−50S
溶離液 30mM Na2HPO4
UV吸収(220nm)検出器:GL7450(GL サイエンス製)
TC検出器:LCT−100(東レエンジニアリング製)
を用いて、ヒューミクル及び段戸産フルボ酸の分子量を測定した。
(2) GPC-UV / TC analysis The GPC-UV / TC analysis method separates dissolved organic substances in water at high speed according to the size of molecules and the degree of exclusion, and separates the separated dissolved molecules into a UV detector and a TC detector (Total Carbon). (Analyzer) is a monitoring method. The following GPC-TC device:
GPC: Shodex GPC SYSTEM 21
Separation column TOSO HW-50S
Eluent 30 mM Na 2 HPO 4
UV absorption (220 nm) detector: GL7450 (manufactured by GL Sciences)
TC detector: LCT-100 (manufactured by Toray Engineering)
Was used to measure the molecular weights of the fumicle and the fulvic acid from Dando.
両者のTCクロマトグラムでは、段戸産フルボ酸のピーク位置が51分であるのに対して、ヒューミクル4%溶解液では54分であった。ピーク位置の保持時間を、使用した分離カラムの多糖類やPEG(ポリエチレングリコール)の排除特性で換算すると、段戸フルボ酸の分子量は、約4,000であり、ヒューミクル溶解液中の有機物の分子量は、約1,000〜3,000と推定された。 In both TC chromatograms, the peak position of Danfu fulvic acid was 51 minutes, whereas it was 54 minutes for the 4% humicule solution. When the retention time at the peak position is converted into the exclusion characteristics of the polysaccharide and PEG (polyethylene glycol) of the separation column used, the molecular weight of the terraced fulvic acid is about 4,000, and the molecular weight of the organic matter in the Humicle solution Was estimated to be about 1,000 to 3,000.
ピークトップとなった保持時間でのTC出力値(mV)とUV(220nm)吸収での出力値(mV)、及びUV出力値/TC出力値(単位有機物量(炭素量)当たりUV吸収の強さ)を表2に示す。 TC output value (mV) at the retention time at the peak top, output value (mV) at UV (220 nm) absorption, and UV output value / TC output value (intensity of UV absorption per unit organic substance amount (carbon amount)) The results are shown in Table 2.
表2から、ヒューミクル溶解液のUV/TC値は、段戸産フルボ酸溶解液のものにほぼ近い。有機物の分子構造に由来する紫外吸光(220nm)に類似性があることは、両者の分子構造の骨格や官能基の種類に類似性があることを示している。 From Table 2, the UV / TC value of the Humicle solution is nearly similar to that of the Danto fulvic acid solution. The similarity in ultraviolet absorption (220 nm) derived from the molecular structure of organic matter indicates that there is similarity in the skeleton and functional group types of both molecular structures.
(3)フーリエ変換赤外分光光度計法(FT−IR)
前記フルボ酸分画のATR法(Attenuated Total Reflection、全反射吸収法)にて赤外線吸収スペクトルを取得した。具体的には、前記フルボ酸分画をDax−8樹脂(Spelco社製)に施用し、そこに吸着した有機物をアルカリ性溶液で脱着した。脱着した有機物を、さらにイオン交換樹脂に通して不要な塩類を取り除いた。得られた試料をATR法に基づくFT−IR分光分析(PerkinElmer Spectrum 65)に供した。
(3) Fourier transform infrared spectrophotometer method (FT-IR)
An infrared absorption spectrum was obtained by the ATR method (Attenuated Total Reflection, total reflection absorption method) of the fulvic acid fraction. Specifically, the fulvic acid fraction was applied to Dax-8 resin (manufactured by Spelco), and the organic matter adsorbed thereon was desorbed with an alkaline solution. The desorbed organic substance was further passed through an ion exchange resin to remove unnecessary salts. The obtained sample was subjected to FT-IR spectroscopic analysis (PerkinElmer Spectrum 65) based on the ATR method.
腐植抽出物(ヒューミクル)に含有されるフルボ酸の赤外線吸収スペクトルを図1に示す。比較のため、段戸産のフルボ酸及びフミン酸の赤外線吸収スペクトルを図2に示す。図1(ヒューミクル)及び図2(段戸産フルボ酸)から主要な赤外線吸収ピークをそれぞれ抽出し、その結果を波数で表3に示す。 FIG. 1 shows an infrared absorption spectrum of fulvic acid contained in the humus extract (humicicle). For comparison, FIG. 2 shows infrared absorption spectra of fulvic acid and humic acid produced in Danto. Major infrared absorption peaks were extracted from FIG. 1 (Humicle) and FIG. 2 (Stepbo fulvic acid), and the results are shown in Table 3 in terms of wave number.
ヒューミクルに含有されるフルボ酸及び段戸産フルボ酸は、共通して1200cm−1にカルボキシル基(C−O)吸収ピークを有するが、そのレベルは、ヒューミクルの方が段戸産フルボ酸よりも小さい。ヒューミクル中のフルボ酸が段戸産フルボ酸のスペクトルと明確に相違する点は、1559、1047及び835cm−1にトリ置換ベンゼンタイプのシグナルが観測され、そして3362及び1360cm−1にフェノールあるいはアルコールタイプのシグナルが観測されることである。 The fulvic acid contained in the fumicle and the fulvic acid produced from the terraced house have a carboxyl group (CO) absorption peak at 1200 cm −1 in common, but the level of the humicule is higher than that of the fulvic acid produced from the terraced house. small. That fulvic acid in Hyumikuru is clearly different spectrum of Danto producing fulvic acids are 1559,1047 and tri-substituted benzene type signals were observed at 835 cm -1, and phenol or an alcohol type 3362 and 1360 cm -1 Is observed.
赤外分光分析の結果は、ヒューミクル中のフルボ酸が段戸産フルボ酸よりもカルボキシル基が少なく、トリ置換ベンゼンタイプのフェノール化合物の構造を多いことを示唆する。発明を限定する意図ではないが、この分子構造の違いが、後述の実施例と比較例に示すように、毛乳頭細胞の増殖率の相違に反映したと考えられる。すなわち、本発明で特定する特定の赤外線吸収スペクトル特性を有する中のフルボ酸を含有する腐植抽出物が有効量添加された育毛剤は、腐植物質を含む従来の育毛剤よも優れた効能を有する。 The results of infrared spectroscopic analysis suggest that the fulvic acid in the humicle has fewer carboxyl groups than the dansted fulvic acid, and has more trisubstituted benzene type phenolic compounds. Although not intended to limit the invention, it is considered that this difference in molecular structure is reflected in a difference in the proliferation rate of hair papilla cells as shown in Examples and Comparative Examples described later. That is, the hair restorer to which an effective amount of a humus extract containing fulvic acid having the specific infrared absorption spectrum characteristic specified in the present invention is added has an effect superior to that of a conventional hair restorer containing humic substances. .
本発明の経皮用育毛剤には、上記の腐植抽出物以外に、化粧品学的、皮膚病学的及び/又は薬学的に許容される添加剤として汎用されるものが添加される。例えば、水;エチレングリコール、ポリエチレングリコール、プロピレングリコール、1,3−ブチレングリコール、1,4−ブチレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、ポリグリセリン、ペンチレングリコール、イソプレングリコール、グルコース、マルトース、フルクトース、キシリトール、ソルビトール、マルトトリオース、エリスリトール等の多価アルコール;メタノール、エタノール、プロピルアルコール、イソプロピルアルコール、ブチルアルコール、イソブチルアルコール等の低級アルコール;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;オリーブ油、トウモロコシ油、ツバキ油、マカデミアナッツ油、アボカド油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油等の油脂;カルナバロウ、キャンデリラロウ、ミツロウ、ラノリン等のロウ類;ソルビトール、マンニトール、グルコース、ショ糖、ラクトース、トレハロース等の糖類;カラギーナン、キサンタンガム、ゼラチン、ペクチン、アガロース、アルギン酸塩、デキストリン、メチルセルロース、エチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、カルボキシビニルポリマー、ポリビニルアルコール、ポリビニルピロリドン、アラビアガム、カラヤガム、トラガントガム、タマリンドガム等の増粘剤;フェノキシエタノール、メチルパラベン、エチルパラベン、プロピルパラベン、ブチルパラベン、パラオキシ安息香酸エステル、安息香酸、サリチル酸とその塩類、ソルビン酸とその塩類、デヒドロ酢酸とその塩類、クロルクレゾール、ヘキサクロロフェン等の防腐剤;ラウロイル硫酸ナトリウム、モノオレイン酸ポリオキシエチレンソルビタン等の非イオン界面活性剤、アルキルサルフェート塩、ノルマルドデシルベンゼンスルホン酸ナトリウム等の陰イオン界面活性剤、ポリオキシエチレンドデシルモノメチルアンモニウムクロライド等の陽イオン界面活性剤;ステロイド系及び非ステロイド系抗炎症剤;ビタミンA、ビタミンD、ビタミンE、ビタミンF、ビタミンK等のビタミン類やジカプリル酸ピリドキシン、ジパルミチン酸ピリドキシン、ジパルミチン酸アスコルビル、モノパルミチン酸アスコルビル、モノステアリン酸アスコルビル等のビタミン誘導体;フラボノイド、カロテノイド等の抗酸化剤;スクワラン、スクワレン、流動パラフィン等の高級脂肪族炭化水素類;セラミド、セレブロシド、スフィンゴミエリン等のスフィンゴ脂質;コレステロール、フィトステロール等のステロール類;メチルポリシロキサン、メチルフェニルポリシロキサン、メチルシクロポリシロキサン、オクタメチルシクロテトラシロキサン、オクタメチルシクロペンタシロキサン、デカメチルシクロペンタシロキサン、メチルハイドロジェンポリシロキサン等のシリコーン類;パラアミノ安息香酸、パラアミノ安息香酸モノグリセリンエステル、アントラニル酸メチル、ホモメンチル−N−アセチルアントラニレート、パラメトキシケイ皮酸オクチル、エチル−4−イソプロピルシンナメート等の紫外線吸収剤;ベントナイト、スメクタイト、バイデライト、ノントロナイト、サポナイト、ヘクトライト、ソーコナイト、スチーブンサイト等の鉱物;ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛等の無機顔料;赤色202号、黄色4号、青色404号等の着色料;香料;香油等が挙げられる。 In addition to the above-mentioned humus extract, those commonly used as cosmetically, dermatologically and / or pharmaceutically acceptable additives are added to the hair growth agent for transdermal use of the present invention. For example, water; ethylene glycol, polyethylene glycol, propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, dipropylene glycol, glycerin, diglycerin, polyglycerin, pentylene glycol, isoprene glycol, glucose, maltose, Polyhydric alcohols such as fructose, xylitol, sorbitol, maltotriose, erythritol; lower alcohols such as methanol, ethanol, propyl alcohol, isopropyl alcohol, butyl alcohol, isobutyl alcohol; oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid Higher fatty acids such as acid, stearic acid, behenic acid, undecylenic acid; olive oil, corn oil, camellia oil, macadamia Oil, avocado oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, etc .; waxes such as carnauba wax, candelilla wax, beeswax, lanolin; sorbitol, mannitol, glucose Sugars such as sucrose, lactose, trehalose; carrageenan, xanthan gum, gelatin, pectin, agarose, alginate, dextrin, methylcellulose, ethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, carboxymethylcellulose, carboxyvinyl polymer, polyvinyl alcohol, polyvinylpyrrolidone, Thickeners such as gum arabic, karaya gum, tragacanth gum, tamarind gum; phenoxyethanol, methyl paraben, ethyl paraben, propyl parabe , Butylparaben, paraoxybenzoic acid ester, benzoic acid, salicylic acid and its salts, sorbic acid and its salts, dehydroacetic acid and its salts, chlorcresol, hexachlorophene, etc .; preservatives such as sodium lauroyl sulfate, polyoxyethylene sorbitan monooleate Nonionic surfactants such as alkyl sulfate salts, anionic surfactants such as sodium normal dodecylbenzenesulfonate, and cationic surfactants such as polyoxyethylene dodecyl monomethylammonium chloride; steroidal and nonsteroidal anti-inflammatory agents Vitamins such as vitamin A, vitamin D, vitamin E, vitamin F, vitamin K, pyridoxine dicaprylate, pyridoxine dipalmitate, ascorbyl dipalmitate, ascorbyl monopalmitate, Vitamin derivatives such as ascorbyl nostearate; antioxidants such as flavonoids and carotenoids; higher aliphatic hydrocarbons such as squalane, squalene and liquid paraffin; sphingolipids such as ceramide, cerebroside and sphingomyelin; sterols such as cholesterol and phytosterols Silicones such as methylpolysiloxane, methylphenylpolysiloxane, methylcyclopolysiloxane, octamethylcyclotetrasiloxane, octamethylcyclopentasiloxane, decamethylcyclopentasiloxane, methylhydrogenpolysiloxane; paraaminobenzoic acid, paraaminobenzoic acid Acid monoglycerol ester, methyl anthranilate, homomenthyl-N-acetylanthranilate, octyl paramethoxycinnamate, ethyl -UV absorbers such as isopropyl cinnamate; minerals such as bentonite, smectite, beidellite, nontronite, saponite, hectorite, soconite, stevensite; bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, Inorganic pigments such as titanium oxide and zinc oxide; coloring agents such as red 202, yellow 4 and blue 404; fragrances; fragrance oils and the like.
本発明の経皮用育毛剤の形態の例は、水剤、液剤、乳剤、乳液、エマルション、クリーム、粉体、及びクレイパックである。皮膚への直接の効果を引き出すために、経皮用育毛剤は、水剤、液剤、乳剤、乳液、エマルション、又はクリームの形態が好ましい。 Examples of the form of the hair growth agent for transdermal use of the present invention are a liquid agent, a liquid agent, an emulsion, an emulsion, an emulsion, a cream, a powder, and a clay pack. In order to bring out a direct effect on the skin, the hair growth agent for transdermal use is preferably in the form of a solution, solution, emulsion, emulsion, emulsion or cream.
本発明の経皮用育毛剤は、シャンプー、リンス、リンスインシャンプー等の頭髪用入浴剤;ヘアミスト、ヘアスプレー、ヘアフォーム、ヘアリキッド等の頭髪用化粧品に含有させ、これらの入浴剤や化粧品にさらに育毛作用を付加してもよい。 The transdermal hair restorer of the present invention is contained in hair cosmetics such as shampoos, rinses and rinse-in shampoos; hair cosmetics such as hair mists, hair sprays, hair foams, hair liquids, and the like. A hair restoring action may be added.
本発明の経皮用育毛剤中の腐植抽出物(フルボ酸を約3%含有)の含有量は、有効量であればよく、通常、0.001〜20重量%でよく、好ましくは0.01〜20重量%であり、さらに好ましくは0.05〜15重量%であり、特に好ましくは0.1〜10重量%である。 The content of the humus extract (containing about 3% fulvic acid) in the hair growth agent for transdermal use of the present invention may be an effective amount, usually 0.001 to 20% by weight, preferably 0. It is 01-20 weight%, More preferably, it is 0.05-15 weight%, Especially preferably, it is 0.1-10 weight%.
本発明の経皮用育毛剤の1回当たりの適用量もまた、年齢、発毛状況、個人差等に応じて有効量であればよい。 The applied amount of the percutaneous hair restorer of the present invention may be an effective amount depending on age, hair growth status, individual differences and the like.
本発明の経口用育毛剤は、汎用の食品添加物を添加してもよい。例えば、経口投与の形態に応じて、汎用の賦形剤、崩壊剤、結合剤、滑沢剤、ビタミン、キサンチン誘導体、アミノ酸、pH調整剤、清涼化剤、懸濁化剤、粘稠剤、溶解補助剤、抗酸化剤、コーティング剤、可塑剤、界面活性剤、水、アルコール類、水溶性高分子、甘味料、矯味剤、酸味料、香料、着色剤等を発明の効果を損なわない質的及び量的範囲で添加することが可能である。 A general food additive may be added to the oral hair restorer of the present invention. For example, depending on the form of oral administration, general-purpose excipients, disintegrants, binders, lubricants, vitamins, xanthine derivatives, amino acids, pH adjusters, cooling agents, suspending agents, thickeners, Solubilizing agents, antioxidants, coating agents, plasticizers, surfactants, water, alcohols, water-soluble polymers, sweeteners, corrigents, acidulants, fragrances, coloring agents, etc. It is possible to add in the target and quantitative range.
本発明の経口用育毛剤の形態は、例えば、散剤、顆粒剤、カプセル剤、丸剤、錠剤、チュアブル錠、ドロップ、水剤、シロップ、及びドリンク剤のような通常の食品とは異なる経口投与剤に加工される。 The form of the oral hair restorer of the present invention is different from ordinary foods such as powders, granules, capsules, pills, tablets, chewable tablets, drops, liquids, syrups and drinks. It is processed into an agent.
本発明の経口用育毛剤中の腐植抽出物(フルボ酸を約3%含有)の含有量は、有効量であればよく、通常、0.1〜70重量%でよく、好ましくは0.1〜30重量%であり、より好ましくは0.1〜15重量%である。 The content of the humus extract (containing about 3% fulvic acid) in the oral hair restorer of the present invention may be an effective amount, usually 0.1 to 70% by weight, preferably 0.1. -30% by weight, more preferably 0.1-15% by weight.
本発明の経口用育毛剤の1日当たりの摂取量もまた、年齢、発毛状況、個人差等に応じて有効量であればよい。 The daily intake of the oral hair restorer of the present invention may also be an effective amount depending on age, hair growth status, individual differences and the like.
以下に、本発明の実施例及び比較例を示すことにより、本発明をより詳細に説明する。しかし、本発明は、以下の実施例に限定されるものではない。 Hereinafter, the present invention will be described in more detail by showing Examples and Comparative Examples of the present invention. However, the present invention is not limited to the following examples.
〔実施例1、比較例1〜4〕
本発明の育毛剤が育毛作用を有するか否かを、毛乳頭細胞の実験モデル系である毛乳頭細胞増殖効果試験(in vitro)で調べた。具体的には、毛乳頭細胞へ本発明の育毛剤を添加し、MTTアッセイによって毛乳頭細胞の細胞増殖促進率を測定し、さらに毛乳頭細胞増殖率を算出した。
[Example 1, Comparative Examples 1 to 4]
Whether or not the hair-restoring agent of the present invention has a hair-growing action was examined by a hair papilla cell proliferation effect test (in vitro), which is an experimental model system for hair papilla cells. Specifically, the hair growth agent of the present invention was added to the hair papilla cells, the cell growth promotion rate of the hair papilla cells was measured by MTT assay, and the hair papilla cell growth rate was calculated.
1.育毛剤試験品の準備
実施例1として、米国ユタ産の腐植の水性抽出物を乾固した腐植抽出物製品「ヒューミクル」(株式会社スタイルアンドバリュージャパン製)を用意した。ヒューミクルに含まれるフルボ酸分画の物性は、上記したとおりである。
1. Preparation of Hair Growth Agent Test Product As Example 1, a humus extract product “Humicle” (manufactured by Style and Value Japan Co., Ltd.) obtained by drying an aqueous extract of humus produced in Utah, USA was prepared. The physical properties of the fulvic acid fraction contained in the vehicle are as described above.
また、本発明の育毛剤の効果を評価するための陽性対照として、従来、育毛作用の知られているフィナステリドを用意した。また、コントロール(陰性対照)として、培地(試験品添加無し)を採用した。さらに、本発明を満たさない腐植物質を含む育毛剤と本発明の育毛剤とを対比するために、以下に示す腐植抽出物を含む製品、及び標準フルボ酸を用意した。
比較例1:果物や植物の発酵により得られたフルボ酸100%のM社製健康飲料
比較例2:長崎県北高来郡森山町唐比西産の腐植抽出物(フルボ酸)を含んだN社製清涼飲料水
比較例3:段戸産フルボ酸(腐植酸標準物質、日本腐植物質学会製)
比較例4:琵琶湖産フルボ酸(腐植酸標準物質、日本腐植物質学会製)
As a positive control for evaluating the effect of the hair restorer of the present invention, finasteride, which has been conventionally known for its hair restoring action, was prepared. As a control (negative control), a medium (no test product added) was employed. Furthermore, in order to compare the hair-restoring agent containing the humic substance which does not satisfy | fill this invention, and the hair-restoring agent of this invention, the product containing the humus extract shown below and the standard fulvic acid were prepared.
Comparative Example 1: 100% fulvic acid obtained by fermentation of fruits and plants, health drink manufactured by M Company Comparative Example 2: Company N containing humus extract (fulvic acid) from Karabi, Moriyama-cho, Kitakagi-gun, Nagasaki Prefecture Soft drink comparative example 3: Danto fulvic acid (humic acid reference material, manufactured by Japanese Society of Humic Substances)
Comparative example 4: Lake Biwa fulvic acid (humic acid reference material, manufactured by Japanese Humic Society)
2.ヒト頭髪毛乳頭細胞の基礎培養
試験用細胞には、ヒト頭髪毛乳頭細胞(タカラバイオ社製)を用いた。培養フラスコ(培養面積75cm2)にヒト頭髪毛乳頭細胞培地及びヒト頭髪毛乳頭細胞懸濁液を培養液中の細胞の最終濃度が2.5×104cells/mL、全量10mLとなるように添加し、CO2インキュベーター(37℃、CO2 5%)で、7日培養して必要細胞数を確保した。
2. Basic culture of human hair papilla cells Human hair papilla cells (manufactured by Takara Bio Inc.) were used as test cells. In a culture flask (culture area 75 cm 2 ), the human hair dermal papilla cell culture medium and the human hair dermal papilla cell suspension are adjusted to a final concentration of 2.5 × 10 4 cells / mL in the culture solution and a total volume of 10 mL. The cells were added and cultured in a CO 2 incubator (37 ° C., CO 2 5%) for 7 days to ensure the necessary number of cells.
3.試験品溶液の調製
実施例1及び比較例1〜4の育毛剤試験品を、それぞれ、試験品濃度が125、31.25、7.81、1.95、0.48、又は0.12μg/mlとなるように、順次、毛乳頭細胞培地で希釈した。陽性対照のFinasterideは、3ng/mLとなるように希釈した。
3. Preparation of test article solution The hair growth agent test articles of Example 1 and Comparative Examples 1 to 4, respectively, had a test article concentration of 125, 31.25, 7.81, 1.95, 0.48, or 0.12 μg / Diluted sequentially with hair papilla cell culture medium to a volume of ml. The positive control Finasteride was diluted to 3 ng / mL.
4.細胞増殖能評価試験
4.1 ヒト頭髪毛乳頭細胞の培養
培養したヒト頭髪毛乳頭細胞をTrypsin処理により培養フラスコから回収し、細胞数をカウントした。細胞を毛乳頭細胞培地で懸濁し、細胞濃度が1×104cells/mLの細胞懸濁液を調製した。調製した細胞懸濁液を試験プレート(96well micro plate)に0.2mLずつ、各wellに添加し、室温で20分静置した。CO2インキュベーター(37℃、CO2 5%)にて18時間の前培養した。前培養後、試験プレート各ウェルの培地と調製した試験品溶液を置き換え、さらにCO2インキュベーター(37℃、CO2 5%)にて72時間培養した。72時間後、MTTアッセイによる生存率を確認した。※独立3回にて試験結果を算出した。
4). 4. Cell Proliferation Evaluation Test 4.1 Culture of human hair dermal papilla cells Cultured human hair dermal papilla cells were collected from the culture flask by trypsin treatment, and the number of cells was counted. Cells were suspended in a hair papilla cell medium to prepare a cell suspension having a cell concentration of 1 × 10 4 cells / mL. 0.2 mL of the prepared cell suspension was added to each well on a test plate (96 well micro plate), and allowed to stand at room temperature for 20 minutes. Pre-cultured for 18 hours in a CO 2 incubator (37 ° C., CO 2 5%). After the preculture, the medium in each well of the test plate was replaced with the prepared test solution, and further cultured in a CO 2 incubator (37 ° C., CO 2 5%) for 72 hours. After 72 hours, viability was confirmed by MTT assay. * Test results were calculated three times independently.
4.2 MTTアッセイ
培養終了後のプレートの培地を捨て、新たにMTT試薬含有培地(1mgMTT/mL培地)を0.1mLずつ各Wellに添加した。CO2インキュベーター(37℃、CO2 5%)にて3時間培養し、呈色反応を行った。MTT可溶化溶液(イソプロパノール)を0.1mLずつ各wellに添加し、生細胞に取り込まれたMTTを抽出した。マイクロプレートリーダーを使用してMTT抽出液の吸光度を570nmで測定した。下記式に示すように、コントロール(試験品未処理細胞)の吸光度を100とした場合の百分率で細胞増殖率を算出した。
4.3 試験データ及び統計解析
得られたデータについて、分散分析を行い、等分散が確認された場合には統計解析として対応のないt検定を実施し、対照区との比較を実施した。試験結果を表4及び図5に示す。
4.3 Test data and statistical analysis An analysis of variance was performed on the obtained data. When equal variance was confirmed, an uncorresponding t-test was performed as a statistical analysis, and a comparison with a control group was performed. The test results are shown in Table 4 and FIG.
陽性対照である濃度(3ng/ml)のフィナステリドは、コントロール(細胞増殖率100%)に対して、106.8±0.6%の毛乳頭細胞増殖率を示し、毛乳頭細胞増加活性が確認された。 Finasteride at a concentration (3 ng / ml), which is a positive control, showed a hair papillary cell proliferation rate of 106.8 ± 0.6% relative to the control (cell growth rate 100%), confirming hair papillary cell increasing activity. It was done.
それに対して、本発明の育毛剤(実施例1)は、濃度0.48〜125μg/mlにおいて、107.4〜116.2%の細胞増殖率を示した。特に、実施例1の濃度1.95μg/mlでの毛乳頭細胞増殖率116.2%は、陽性対照に対して1.09倍(=116.2/106.8)上回る増殖活性を示した。 On the other hand, the hair restorer of the present invention (Example 1) showed a cell growth rate of 107.4 to 116.2% at a concentration of 0.48 to 125 μg / ml. In particular, the dermal papilla cell proliferation rate of 116.2% at a concentration of 1.95 μg / ml in Example 1 showed 1.09 times (= 116.2 / 106.8) greater proliferation activity than the positive control. .
次に、比較例3(段戸酸フルボ酸)及び比較例4(琵琶湖酸)は、日本腐植学会標準品のフルボ酸である。比較例3及び4を実施例1と対比すると、比較3及び4は、フルボ酸濃度0.48〜125μg/mlにおいて実施例1と似た傾向を示したが、その細胞増殖率は、99.8〜106.7%(比較例3)及び96.4〜102.7%(比較例4)と、実施例1よりも劣った。 Next, Comparative Example 3 (stepped acid fulvic acid) and Comparative Example 4 (Lake Lake acid) are fulvic acids that are standard products of the Japanese Humic Society. When Comparative Examples 3 and 4 were compared with Example 1, Comparatives 3 and 4 showed a tendency similar to Example 1 at a fulvic acid concentration of 0.48 to 125 μg / ml, but the cell growth rate was 99.99. 8-106.7% (Comparative Example 3) and 96.4-102.7% (Comparative Example 4), inferior to Example 1.
比較例1は、本発明に使用する腐植抽出物と違って、果物や植物を出発材料として人工的に合成したフルボ酸である。比較例2は、特許文献1及び2の実施例で使用された長崎県北高来郡森山町唐比西産の腐植抽出物と推定される。これらの比較例1及び2を、実施例1と対比すると、比較例1及び2の細胞増殖率は、それぞれ、86.1〜104.4%、及び94.2〜101.2%と実施例1よりも明らかに劣った。 Comparative Example 1 is a fulvic acid artificially synthesized using fruits and plants as starting materials, unlike the humus extract used in the present invention. Comparative Example 2 is presumed to be a humus extract produced in Karabi, Moriyama-cho, Moritaka-machi, Kitakagi-gun, Nagasaki Prefecture, which was used in Examples of Patent Documents 1 and 2. When these Comparative Examples 1 and 2 are compared with Example 1, the cell growth rates of Comparative Examples 1 and 2 are 86.1 to 104.4% and 94.2 to 101.2%, respectively. Obviously inferior to 1.
以上の結果から、特定の腐植抽出物を含む本発明の育毛剤は、毛乳頭細胞増殖活性が知られているフィナステリド、腐植抽出物標準品、及び腐植抽出物を含む既存の育毛剤製品よりも高い毛乳頭細胞増殖活性があることが判明した。したがって、本発明の育毛剤は、優れた育毛作用を有する育毛剤としての産業上の利用性が期待される。 From the above results, the hair restorer of the present invention containing a specific humus extract is more effective than finasteride, a humus extract standard product, and an existing hair restorer product containing a humus extract, which are known to have hair papilla cell proliferation activity. It was found to have high hair papilla cell proliferation activity. Accordingly, the hair growth agent of the present invention is expected to be industrially useful as a hair growth agent having an excellent hair growth action.
Claims (8)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017000752A JP6233999B1 (en) | 2017-01-05 | 2017-01-05 | Hair restorer |
PCT/JP2017/046295 WO2018128104A1 (en) | 2017-01-05 | 2017-12-25 | Hair growth promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017000752A JP6233999B1 (en) | 2017-01-05 | 2017-01-05 | Hair restorer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP6233999B1 JP6233999B1 (en) | 2017-11-22 |
JP2018108974A true JP2018108974A (en) | 2018-07-12 |
Family
ID=60417525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017000752A Active JP6233999B1 (en) | 2017-01-05 | 2017-01-05 | Hair restorer |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6233999B1 (en) |
WO (1) | WO2018128104A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019019108A (en) * | 2017-07-20 | 2019-02-07 | 学校法人 中村産業学園 | 5α-REDUCTASE INHIBITOR, AND COMPOSITION FOR PREVENTIVE TREATMENT OF ALOPECIA OR HAIR GROWTH PROMOTION, AND METHOD FOR INHIBITING 5α-REDUCTASE IN SCALP AND HAIR GROWTH PROMOTION METHOD |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112972313A (en) * | 2021-03-08 | 2021-06-18 | 德利宝(广州)香料有限公司 | Preparation method of modified humus extract and shampoo composition containing modified humus extract |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006327978A (en) * | 2005-05-25 | 2006-12-07 | Myubio Co Ltd | Hair grower |
WO2007102813A1 (en) * | 2006-03-07 | 2007-09-13 | Advantage Marketing, Inc. | Compositions and methods for human use containing fulvic acid |
JP2013107857A (en) * | 2011-11-22 | 2013-06-06 | Funao Kurosawa | Skin external preparation |
-
2017
- 2017-01-05 JP JP2017000752A patent/JP6233999B1/en active Active
- 2017-12-25 WO PCT/JP2017/046295 patent/WO2018128104A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006327978A (en) * | 2005-05-25 | 2006-12-07 | Myubio Co Ltd | Hair grower |
WO2007102813A1 (en) * | 2006-03-07 | 2007-09-13 | Advantage Marketing, Inc. | Compositions and methods for human use containing fulvic acid |
JP2013107857A (en) * | 2011-11-22 | 2013-06-06 | Funao Kurosawa | Skin external preparation |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019019108A (en) * | 2017-07-20 | 2019-02-07 | 学校法人 中村産業学園 | 5α-REDUCTASE INHIBITOR, AND COMPOSITION FOR PREVENTIVE TREATMENT OF ALOPECIA OR HAIR GROWTH PROMOTION, AND METHOD FOR INHIBITING 5α-REDUCTASE IN SCALP AND HAIR GROWTH PROMOTION METHOD |
JP2022008886A (en) * | 2017-07-20 | 2022-01-14 | 学校法人 中村産業学園 | 5α-REDUCTASE INHIBITOR, AND COMPOSITION FOR PREVENTIVE TREATMENT OF ALOPECIA OR HAIR GROWTH PROMOTION, AND METHOD FOR INHIBITING 5α-REDUCTASE IN SCALP AND HAIR GROWTH PROMOTION METHOD |
JP7046304B2 (en) | 2017-07-20 | 2022-04-04 | 学校法人 中村産業学園 | A method for producing a 5α-reductase inhibitor, and a method for producing a composition for preventing and treating alopecia or promoting hair growth. |
Also Published As
Publication number | Publication date |
---|---|
JP6233999B1 (en) | 2017-11-22 |
WO2018128104A1 (en) | 2018-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201438756A (en) | External dermal composition for anti-ageing and method for producing the same | |
JP4831849B2 (en) | Active oxygen scavenger and its use | |
JP6233999B1 (en) | Hair restorer | |
JP2008063266A (en) | Anti-aging agent, bleaching agent, anti-oxidizing agent and anti-inflammatory agent | |
JP6120342B1 (en) | Beauty composition | |
WO2023094517A1 (en) | A topical composition | |
JP2009209063A (en) | Skin preparation for external use, or skin cosmetic | |
JP4155430B2 (en) | Skin aging inhibitor and use thereof | |
JP2010018545A (en) | Active oxygen scavenger, and skin care preparation for external use, composition for oral cavity and food | |
JP5465037B2 (en) | Anti-aging agent, antioxidant, whitening agent, immunostimulant, external preparation for skin and functional oral composition | |
JP2008303180A (en) | Skin-lightening agent, skincare preparation for external use, and functional oral composition | |
JP2008247841A (en) | Skin-lightening agent and melanin generation inhibitor | |
JP5025201B2 (en) | Moisturizer, anti-aging agent, whitening agent, anti-inflammatory agent, and antioxidant | |
JP6739944B2 (en) | External preparation for skin or cosmetics | |
JP2013224318A (en) | Active oxygen scavenger, skin care preparation, composition for oral cavity and food product | |
JP2003113066A (en) | Cosmetic | |
KR102572519B1 (en) | A cosmetic composition for skin whitening containing loess extract | |
KR101028701B1 (en) | Cosmetic compostions comprising Camellia japonica stamen with pollen and its extract for improving skin | |
JP7454203B2 (en) | Skin external preparations or internal preparations | |
JPH08333270A (en) | Cell activator | |
JP5610846B2 (en) | Anti-aging agent, antioxidant, anti-inflammatory agent, whitening agent, moisturizer, external preparation for skin and functional oral composition | |
JP2006347934A (en) | Glutathione production accelerator | |
EP2571483B1 (en) | A personal care composition | |
KR20220088317A (en) | Anti-aging composition comprising fermented propolis | |
WO2013149791A1 (en) | A personal care composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170825 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171002 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171023 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6233999 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |